Understanding Prognostic Factors for Human Papillomavirus Vaccination: A Rural Community Case–Control Study

dc.contributor.authorColomé Ceballos, Lara
dc.contributor.authorClua Espuny, Josep Lluís
dc.contributor.authorCeballos García, Concepción
dc.contributor.authorClua Queralt, Josep
dc.contributor.authorPla Farnós, Maria Jesús
dc.contributor.authorFernández Sáez, José
dc.date.accessioned2023-12-11T14:48:58Z
dc.date.available2023-12-11T14:48:58Z
dc.date.issued2023-09-28
dc.date.updated2023-11-27T15:29:54Z
dc.description.abstractHPV vaccination coverage rates can vary depending on several factors. The main objective of this study is to identify possible independent prognostic factors that have an impact on HPV vaccination in a rural community, specifically related to sexual and reproductive health. A case-control, retrospective, community-based study was carried out on women aged 15 to 40 in the primary health centers of Southern Catalonia's Terres de l'Ebre region, Spain, from 1 January 2020 to 31 December 2022. A random sample of 520 women with an average age of 29.3 (SD 7.8) years old was included in the study. Independent prognostic factors: age OR 0.680 (95% CI: 0.635-0.729, p < 0.001), immigrant origin OR 0.215 (95% CI: 0.109-0.422, p < 0.001), and HPV PCR OR 7.402 (95% CI: 2.504-21.880, p < 0.001). The variables that showed a barrier effect for HPV vaccination were age (OR 0.680, 95% CI 0.635-0.729, p < 0.001), and immigrant origin (OR 0.215, 95% CI 0.109-0.422, p < 0.001). The variable that showed a facilitating effect for HPV vaccination was HPV PCR (OR 7.402, 95% CI 2.504-21.880, p < 0.001).
dc.format.extent15 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn2076-393X
dc.identifier.pmid37896940
dc.identifier.urihttps://hdl.handle.net/2445/204480
dc.language.isoeng
dc.publisherMDPI AG
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/vaccines11101536
dc.relation.ispartofVaccines, 2023, vol. 11, num. 10
dc.relation.urihttps://doi.org/10.3390/vaccines11101536
dc.rightscc by (c) Colomé Ceballos, Lara et al, 2023
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationVacuna del papil·lomavirus
dc.subject.classificationCribratge
dc.subject.otherPapillomavirus vaccines
dc.subject.otherMedical screening
dc.titleUnderstanding Prognostic Factors for Human Papillomavirus Vaccination: A Rural Community Case–Control Study
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
vaccines-11-01536.pdf
Mida:
2.19 MB
Format:
Adobe Portable Document Format